Gastrointestinal Pathogen News
-
Lumen Bioscience Receives Broad Funding Support for Advancement of Antibiotic Alternative for Preventing Traveler’s Diarrhea
Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced several funding milestones supporting the development of its therapeutics to prevent serious diarrheal diseases. The first is a $5 million grant from the Bill & Melinda Gates Foundation for a second Phase 2 study of an improved anti-campylobacter therapeutic, ...
-
Lumen Bioscience Announces Publication in Nature Biotechnology Detailing Spirulina-Based Platform for Ultra-Large-Scale Production of Therapeutic Proteins
Researchers describe rapid, low-cost drug development approach Paper also reports preclinical and early clinical data for LMN-101 A common food source has been converted into a biomanufacturing platform that offers a way to rapidly produce mass quantities of biologic drugs for common diseases that currently lack effective treatments. Researchers at Lumen Bioscience report in Nature ...
-
Equine Today: The Importance of Having a Biosecurity Program at your Practice
Fluxergy’s is launching its environmental salmonella assay where equine practices and facilities can add in-house PCR testing to their biosecurity program. This avoids central lab processing and allows clinicians to clear stalls after simple overnight enrichment. Contact Sales What is Biosecurity? Biosecurity describes all the human actions that go into preventing disease in horses and ...
By Fluxergy
-
MV Biotherapeutics and Malcisbo agree to explore the Apyrase technology platform for AH Vaccines
MV Biotherapeutics SA (from now on “MV Bio”), a Swiss microbiome biotherapeutics company and Malcisbo AG (from now on “Malcisbo”), a Swiss company developing carbohydrate-based vaccines are proud to announce a collaboration after winning an Innosuisse grant. Malcisbo and MV Bio have previously signed a contract, which gives Malcisbo the exclusive right to use MV Bio ...
-
Intus Bio Launches the Shoreline Breaker Instrument and HMW DNA Sample Prep Kits to Advance Microbiome Research
Intus Biosciences, a microbiome research company that develops solutions for characterizing microbiome populations down to the strain level, recently unveiled a powerful new high molecular weight (HMW) DNA prep solution supporting microbial metagenomics applications. Not all microbes are created equal: some are easy to lyse, but others can be challenging. The Shoreline BreakerTM technology is ...
-
MV BioTherapeutics to present at 5th Microbiome Movement - Drug Development Europe
We are happy to announce that Fabio Grassi (MV BioTherapeutics founder) has been invited to contribute to the 5th Microbiome Movement – Drug Development Summit Europe 2021 being held virtually during January 27th-29th, 2021. The presentation has been included in the morning stream titled “Introducing the Era of Engineered Microbes” the 29th at 11.35. Leveraging Gut Microbiota ...
-
Reduce antibiotic use in farming
To round off World Antibiotic Awareness Week in November, the Alliance to Save our Antibiotics have produced a report calling for Government to protect public health and take a stronger stance against using antibiotics too much on farms. The US, Australia, New Zealand and Canada, which are all in trade negotiations with the UK, allow farmers to give antibiotics to livestock to make them grow ...
-
Succesfull Bio Digital 2020
MV BioTherapeutics participated for the first time to the international event Bio Digital 2020 presenting the company, the pipeline to over 50 companies. “We weren’t sure about the potential success when we applied to the Swiss Pavillon with the sponsoring of Innosuisse” confirms Dr. Fabio Grassi, founder and chairman. “The support we got from Switzerland Global ...
-
Antibiotic Resistance Threats Identified by the CDC and the Importance of Infection Control Procedures and Education
While much of the media’s attention has been focused on the novel coronavirus that spread across the globe this year, SARS-CoV-2 is not the only emerging threat. Just before reports of the initial outbreak of COVID-19 last year, the Centers for Disease Control and Prevention (CDC) published an update to the agency’s first Antibiotic Resistance Threats in the United States (AR Threats ...
-
Pet Store Puppies and Multidrug-Resistant Campylobacter Infections Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses a recent outbreak of multidrug-resistant Campylobacter infections in people that were linked to contact with pet store puppies. “Earlier this year, the Centers for Disease Control and Prevention (CDC), the U.S. Department of ...
-
Campylobacter and Campylobacteriosis Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production shares information provided by the Centers for Disease Control and Prevention (CDC) about the spiral-shaped bacteria called Campylobacter and the infectious disease known as campylobacteriosis. “The CDC reports that campylobacteriosis usually occurs ...
-
Superbugs: MEPs want to curb use of antibiotics in farming
To fight the growing resistance of bacteria to today’s antibiotics, the use of existing antimicrobial drugs should be restricted, and new ones should be developed, said the European Parliament on Thursday. In a vote on draft plans to update an EU law on veterinary medicines, MEPs advocate banning collective and preventive antibiotic treatment of animals, and back measures to stimulate ...
-
Detecting diseases in the palm of your hand
Portable laboratories the size of your palm, capable of analysing food for diseases such as salmonella, no longer belong in the realms of science fiction. A team of European researchers are on the fast track to producing just such a lab. OptoLabCard, a project funded by the EU to the tune of over EUR 3 million, offers to not only protect the health and well-being of millions of Europeans but also ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you